Status:
COMPLETED
Medico-economic Evaluation of Different High-throughput Sequencing Strategies in the Diagnosis of Patients With Intellectual Deficiency
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Intellectual Deficiency
Eligibility:
All Genders
Brief Summary
Intellectual deficiency (ID) is a veritable public health issue because it affects 1 to 3% of the population at large. Currently, in France, the diagnosis is based on clinical expertise, the use of DN...
Eligibility Criteria
Inclusion
- Patients (children and adults) with intellectual deficiency (ID), whatever the degree
- Absence of a clear clinical diagnosis at the first consultation for the dysmorphology assessment
- Patients who have never undergone genetic investigations
- Consent of the patient or his/her legal representative
- Patient with national health insurance cover
- Samples available from both parents
Exclusion
- Pregnant or breast-feeding women
- Patients presenting learning disorders
Key Trial Info
Start Date :
June 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2023
Estimated Enrollment :
337 Patients enrolled
Trial Details
Trial ID
NCT03287206
Start Date
June 28 2017
End Date
December 16 2023
Last Update
March 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourogne
Dijon, France, 21000